QUEBEC CITY, Sept. 14 /PRNewswire-FirstCall/ - John C. Schafer, newly appointed Chief Executive Officer of DiagnoCure Inc. (TSX CUR), a leading developer of molecular diagnostics for the early detection of cancer, will host a conference call to discuss the company’s short and medium term priorities. Investors and interested parties are invited to join the conference call for a short presentation followed by a question period.
